Electroconvulsive Therapy (ECT) has been widely applied to treat schizophrenia (SCZ) in the presence of resistance to pharmacotherapy. The mechanism of action of ECT in schizophrenia has not been fully clarified, though its intrinsic mechanism presents analogies with some neurobiological processes mediated by nerve growth factor (NGF).
Nerve growth factor serum levels in treatment-resistant schizophrenic patients following electroconvulsive therapy
Pacitti, Francesca;Iannitelli, Angela
2021-01-01
Abstract
Electroconvulsive Therapy (ECT) has been widely applied to treat schizophrenia (SCZ) in the presence of resistance to pharmacotherapy. The mechanism of action of ECT in schizophrenia has not been fully clarified, though its intrinsic mechanism presents analogies with some neurobiological processes mediated by nerve growth factor (NGF).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
394-Articolo-1402-1-10-20201221.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Dominio pubblico
Dimensione
207.36 kB
Formato
Adobe PDF
|
207.36 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
